Northern Trust Corp Gelesis Holdings, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.11 - $0.52 $384 - $1,816
3,494 Added 2.89%
124,418 $19,000
Q4 2022

Feb 13, 2023
BUY
$0.22 - $0.51 $2,343 - $5,433
10,653 Added 9.66%
120,924 $35,000
Q3 2022

Nov 14, 2022
BUY
$0.08 - $1.34 $1,414 - $23,691
17,680 Added 19.09%
110,271 $119,000
Q2 2022

Aug 12, 2022
BUY
N/A
52,951 Added 133.58%
92,591 $143,000
Q1 2022

May 13, 2022
BUY
N/A
39,640 New
39,640 $180,000

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email